L’hyperoxalurie primitive, aujourd’hui et demain

Cochat, Pierre; Cheyssac, Elodie; Sellier‐Leclerc, Anne‐Laure; Bertholet‐Thomas, Aurélia; Bacchetta, Justine; Acquaviva‐Bourdain, Cécile

doi:10.1016/s0001-4079(19)30403-0

Cited by 1 publication

(2 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Vitamin B6 was prescribed for 13 of our patients. Several promising treatments are under investigation such as Oxalobacter formigenes, Lumasiran, Stirpental, gene therapy, and hepatocyte transplantation [1,2]. Combined liver-renal transplantation is the best strategy for CKD.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Primary Hyperoxaluria Type 1: Clinical, Paraclinical, and Evolutionary Aspects in Adults from One Nephrology Center

Hajji

Bettaieb

Kâaroud

et al. 2023

International Journal of Nephrology

View full text Add to dashboard Cite

Introduction. Primary hyperoxaluria type 1 (PH1) is a rare and inherited condition of urolithiasis. The aim of our study was to analyze clinical, paraclinical, and evolutionary aspects of PH1 in adult patients in our Nephrology department. Methods. We conducted a retrospective single-center study between 1990 and 2021. We collected patients followed for PH1 confirmed by genetic study and/or histopathological features of renal biopsy and morphoconstitutional analysis of the calculi. Results. There were 25 patients with a gender ratio of 1.78. The median age at onset of symptoms was 18 years. A delay in diagnosis more than 10 years was noted in 13 cases. The genetic study found the I244T mutation in 17 cases and 33-34 InsC in 4 cases. A kidney biopsy was performed in 5 cases, on a native kidney in 4 cases and on a graft biopsy in one case. The analysis of calculi was done in 10 cases showing type Ic in 2 cases. After a median follow-up of 13 years (1 year–42 years), 14 patients progressed to end-stage chronic renal failure (ESRD). The univariate study demonstrated a remarkable association with progression to ESRD in our population (44% vs. 56%) RR = 13.32 (adjusted ORs (95% CI): 2.82–62.79) ( p < 0.01 ). Conclusion. Progression to ESRD was frequent in our series. Early diagnosis and adequate management can delay such an evolution.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Primary hyperoxaluria type 1 (PH1) is a rare and severe inherited disease affecting glyoxylate and oxalate metabolism [ 1 , 2 ]. It is an autosomal recessive (AR) disorder, classified into 3 types depending on the mutated protein.…”

Section: Introductionmentioning

confidence: 99%